Newman Dignan & Sheerar Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Buy |
786
+25
| +3% | +$11.1K | 0.08% | 142 |
|
|
2025
Q1 | $369K | Buy |
761
+31
| +4% | +$15K | 0.1% | 122 |
|
|
2024
Q4 | $294K | Sell |
730
-36
| -5% | -$14.5K | 0.08% | 142 |
|
|
2024
Q3 | $365K | Buy |
766
+2
| +0.3% | +$953 | 0.09% | 133 |
|
|
2024
Q2 | $358K | Sell |
764
-33
| -4% | -$15.5K | 0.09% | 132 |
|
|
2024
Q1 | $333K | Hold |
797
| – | – | 0.09% | 141 |
|
|
2023
Q4 | $324K | Buy |
797
+34
| +4% | +$13.8K | 0.1% | 133 |
|
|
2023
Q3 | $265K | Buy |
763
+5
| +0.7% | +$1.74K | 0.09% | 140 |
|
|
2023
Q2 | $267K | Sell |
758
-135
| -15% | -$47.5K | 0.08% | 152 |
|
|
2023
Q1 | $281K | Sell |
893
-10
| -1% | -$3.15K | 0.09% | 154 |
|
|
2022
Q4 | $261K | Hold |
903
| – | – | 0.09% | 157 |
|
|
2022
Q3 | $261 | Hold |
903
| – | – | 0.04% | 150 |
|
|
2022
Q2 | $254K | Hold |
903
| – | – | 0.09% | 163 |
|
|
2022
Q1 | $236 | Sell |
903
-20
| -2% | -$5 | 0.05% | 171 |
|
|
2021
Q4 | $203K | Sell |
923
-335
| -27% | -$73.7K | 0.06% | 190 |
|
|
2021
Q3 | $228K | Buy |
1,258
+5
| +0.4% | +$906 | 0.07% | 172 |
|
|
2021
Q2 | $253K | Sell |
1,253
-80
| -6% | -$16.2K | 0.09% | 161 |
|
|
2021
Q1 | $286K | Buy |
+1,333
| New | +$286K | 0.1% | 149 |
|